IDENTIFYING LIVER CANCER BY DETECTING ABERRANT EXPRESSION OF INSULIN LIKE GROWTH FACTOR BINDING PROTEIN

Details for Australian Patent Application No. 2002250733 (hide)

Owner NATIONAL CANCER CENTRE OF SINGAPORE PTE LTD SINGAPORE GENERAL HOSPITAL PTE LTD

Inventors CHOW, Pierce, Kah, Hoe; SOO, Khee, Chee; HUYNH, The Hung

Pub. Number AU-A-2002250733

PCT Pub. Number WO2002/090580

Priority 60/288,441 03.05.01 US

Filing date 3 May 2002

Wipo publication date 18 November 2002

International Classifications

C12Q 001/68 Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

1 May 2003 Application Open to Public Inspection

  Published as AU-A-2002250733

19 February 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002250734-APPARATUS AND METHOD FOR THE TREATMENT OF WASTE

2002250732-Fuel delivery system